↓ Skip to main content

Dove Medical Press

Article Metrics

Emerging therapeutic options for sporadic inclusion body myositis

Overview of attention for article published in Therapeutics and Clinical Risk Management, September 2015
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age (52nd percentile)
  • Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter
3 tweeters

Citations

dimensions_citation
9 Dimensions

Readers on

mendeley
30 Mendeley
Title
Emerging therapeutic options for sporadic inclusion body myositis
Published in
Therapeutics and Clinical Risk Management, September 2015
DOI 10.2147/tcrm.s65368
Pubmed ID
Authors

Lindsay Alfano, Linda P Lowes

Abstract

Sporadic inclusion body myositis is the most common inflammatory muscle disorder preferentially affecting males over the age of 40 years. Progressive muscle weakness of the finger flexors and quadriceps muscles results in loss of independence with activities of daily living and eventual wheelchair dependence. Initial signs of disease are often overlooked and can lead to mis- or delayed diagnosis. The underlying cause of disease is unknown, and disease progression appears refractory to available treatment options. This review discusses the clinical presentation of inclusion body myositis and the current efforts in diagnosis, and focuses on the current state of research for both nonpharmacological and pharmacological treatment options for this patient group.

Twitter Demographics

The data shown below were collected from the profiles of 3 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 30 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 30 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 7 23%
Student > Ph. D. Student 4 13%
Student > Master 4 13%
Student > Bachelor 3 10%
Other 2 7%
Other 5 17%
Unknown 5 17%
Readers by discipline Count As %
Medicine and Dentistry 10 33%
Nursing and Health Professions 4 13%
Neuroscience 3 10%
Psychology 2 7%
Sports and Recreations 1 3%
Other 2 7%
Unknown 8 27%

Attention Score in Context

This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 28 September 2015.
All research outputs
#7,206,480
of 12,485,238 outputs
Outputs from Therapeutics and Clinical Risk Management
#472
of 922 outputs
Outputs of similar age
#109,649
of 247,002 outputs
Outputs of similar age from Therapeutics and Clinical Risk Management
#31
of 56 outputs
Altmetric has tracked 12,485,238 research outputs across all sources so far. This one is in the 40th percentile – i.e., 40% of other outputs scored the same or lower than it.
So far Altmetric has tracked 922 research outputs from this source. They receive a mean Attention Score of 4.1. This one is in the 42nd percentile – i.e., 42% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 247,002 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 52% of its contemporaries.
We're also able to compare this research output to 56 others from the same source and published within six weeks on either side of this one. This one is in the 32nd percentile – i.e., 32% of its contemporaries scored the same or lower than it.